Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective

The rapid emergence of Coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome 2 coronavirus (SARS-CoV-2) as a pandemic that presents an urgent human health crisis. Many SARS-CoV-2 neutralizing antibodies (NAbs) were developed with efficient therapeutic potential. NAbs-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yang, Sun, Hui, Yu, Hai, Li, Shaowei, Zheng, Qingbing, Xia, Ningshao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799234/
https://www.ncbi.nlm.nih.gov/pubmed/33912797
http://dx.doi.org/10.1093/abt/tbaa028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799234/
https://www.ncbi.nlm.nih.gov/pubmed/33912797
http://dx.doi.org/10.1093/abt/tbaa028

Ejemplares similares